TABLE 25Post first stroke health state

Post-stroke health stateProbability (%) by age group (years)
2–78–1819–3031+
Mild27.5019.7520.0017.50
Moderate50.0046.2540.0025.00
Severe22.5033.2532.0045.00
Death0.000.758.0012.50

From: 5, Assessment of cost-effectiveness

Cover of The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 16.43.
Cherry MG, Greenhalgh J, Osipenko L, et al.
Southampton (UK): NIHR Journals Library; 2012 Nov.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.